Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Mar 18, 2009

Premium

Following the retirement of Steven Gutman as director of the US Food and Drug Administration's Office of In Vitro Diagnostics, Don St. Pierre is serving as the acting director of the division until a permanent director can be hired.

OIVD has been interviewing candidates and a permanent director is expected to be hired by this spring, according to Alberto Gutierrez, deputy office director of new product evaluation at OIVD, who spoke at meeting of the HHS Secretary's Advisory Committee on Genetics, Health, and Society this week in Washington, DC.

Furthermore, Gutierrez noted that OIVD has formed a new personalized medicine staff. This staff "is in some ways outside of our current structure, and they will be coordinating outreach and internal issues that have to do with personalized medicine and genomics in our office," he said.


BG Medicine has named Doug White to be executive VP and general manager. White has previously been a senior VP of sales and marketing at Qiagen, and he has worked at Digene, Bayer, Chiron Diagnostics, and Abbott Laboratories.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.